The Outlook for Pharmaceuticals in Northern Europe

Table of Contents

DENMARK BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • Gross Domestic Product, 2007-2012
• POPULATION
  • Population Trends, 2005-2007
  • Population by Region & Gender, 2006
  • Population by Age & Gender, 2006
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 2000-2006
• MORTALITY
  • Causes of Death, 2005
• MORBIDITY
• Cancer Incidence
  • Most Common Types of Cancer Among Male (New Cases), 2003
  • Most Common Types of Cancer Among Female (New Cases), 2003
• HIV / AIDS
  • Diagnosed Cases of AIDS, 1999-2005
  • HIV Cases by mode of transmission, 2000-2005

CHARTS

• Map of Denmark
• Population by Age, 2006 (%)
• Causes of Death, 2005 (%)

DENMARK HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
• HOSPITAL SERVICES
• Hospital Resources
  • Hospitals by Type, 2004
  • Hospitals by Region, 2004
  • Hospital Beds by Region, 1993-2004
  • Hospital Beds by Specialty, 2004
  • Hospital Beds by Specialty, 1996-2000
  • Hospital activity by Year, 2000-2005
  • Hospital Activity Summary by ICD-10 Classification and Year, 2002-2005
  • Hospital Patients, 2003-2005
  • Hospital Admissions, 2003-2005
  • Average length of Stay, 2002-2003
• Private Hospitals
• AMBULATORY CARE
  • Outpatient Activity by Region, 2002-2004
  • Outpatient Activity by Specialty, 2002-2004
• MEDICAL PERSONNEL
  • Persons Employed in the Hospital Sector, 1995-2004
  • Primary Sector Medical Personnel, 1990-1999

CHARTS

• Central Government Expenditure on Health, 2001-2005

DENMARK ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
  • Centralised Procedure
  • The EMEA
  • Mutual Recognition Procedure
• Pharmaceutical Registration
  • Clinical Trials
• Advertising
• Patent Protection & Intellectual Property Rights
  • Supplementary Protection Certificates
• Pricing and Reimbursement
  • Pricing
  • Price Index
  • The Price List of Proprietary Medicinal Products
  • DKMAnet Prices and Packages
  • Generic substitution
  • Reimbursement
• Relationship Between Annual Consumption and Pharmaceutical Reimbursement, 2007
• DISTRIBUTION CHANNELS
  • Pharmacies, 1990 - 2004
• Distributors
  • Amgros
  • Dupharma
  • Missionpharma
• Parallel Imports
• DOMESTIC PRODUCTION
  • Domestic Pharmaceutical Manufacturing Turnover, 2001-2006
• Trade Associations
• Domestic Producers
  • ALK-Abelló
  • Genmab A/S
  • Hexal A/S
  • Leo Pharma
  • Lundbeck A/S
  • Novo Nordisk
  • PharmaDanica
  • Pharmexa
• Research & Development
  • Pharmaceutical Research & Development Expenditure by Lif' s Member Companies, 1990-2000 (DKr Million)
• DIRECTORY
• Government Organisations
• Trade Associations

ESTONIA BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • Economic Indicators, 2004-2011
• POPULATION
  • Population, 1990-2006
  • Population by County, 2000-2006
  • Population by Age, 2000-2006 (%)
• DEMOGRAPHIC INDICATORS
  • Principal Demographic Indicators, 1997-2005
• MORTALITY
  • Causes of Death, 1999-2005
  • Causes of Death, 2005
  • Infant Mortality by Sex and Place of Residence, 2001-2005
  • Infant Mortality by Cause, 2003
• MORBIDITY
  • Selected Notified Infectious Diseases, 1995-2001 (Per 100,000 Population)
    • Tuberculosis
  • Tuberculosis Cases, 1990-2004
    • Cancer
  • New Cancer Cases, 1995-2003
    • HIV/AIDS
  • New Cases of HIV, 1996-2005

CHARTS

• Map of Estonia
• Population by Age Group, 2006 (%)
• Birth, Death and Infant Mortality Rates, 1997-2005
• Leading Causes of Death, 2005 (%)

ESTONIA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
  • Health Expenditure by Source, 1999-2004 (Ekr 000)
  • Health Expenditure by Source, 1999-2004 (%)
  • Health Expenditure by Source, 2004 (Ekr 000)
  • Public Health Expenditure, 2004 (Ekr 000)
  • Private Health Expenditure, 2004 (Ekr 000)
• HOSPITAL SERVICES
• Hospital Resources
  • Hospital Trends, 1995-2004
• Hospital Activity
  • Hospital Activity, 1996-2004
  • Hospital Admissions by Specialty, 1995-2001
  • Average Length of Stay by Specialty, 1995-2001 (Days)
  • Bed Occupancy by Specialty, 1995-2001 (%)
  • Bed Turnover by Specialty, 1995-2001
• Private Hospitals
  • Private Hospital Trends, 1994-2004
  • Private Hospitals & Beds by County, 2001-2004
• AMBULATORY CARE
  • Outpatient Visits Trends, 1996-2004
  • Outpatient Visits by County, 2004
• MEDICAL PERSONNEL
  • Medical Personnel Trends, 1996-2004
  • Doctors by Specialty, 1990-2001
  • Doctors by County, 1999-2004
  • Other Medical Personnel, 1995-2004

CHARTS

• Health Expenditure by Source, 2004 (%)

ESTONIA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• Pharmaceutical Registration
  • Marketing Authorisation
  • Clinical Trials
  • Clinical Trials, 1991-2005
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing and Reimbursement
  • Pharmaceutical Reimbursement Rates and Co-payments, 2001
• DISTRIBUTION CHANNELS
  • Leading Wholesalers by Market Share (%), 2000-2005
  • Sales of Medicinal Products in Retail and Hospital Pharmacies (Ekr millions)
• Distributors
  • Berren OU
  • Magnum Pro Med Ltd.
  • AS Oriola
  • Tamro Eesti AS
  • TopMed AS
• TRADE FAIRS
• Medifar
• DOMESTIC PRODUCTION
• Domestic Producers
  • Tallinna Farmaatsiatehase AS
• DIRECTORY

FINLAND BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • Estimated/Projected GDP 2004-2011
• POPULATION
  • Population, 1990-2005
  • Population by Region, 2000-2005
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 1995-2005
• MORTALITY
  • Registered Causes of Death, 2001-2005
• MORBIDITY
  • Reported Incidence of Infectious Diseases, 2002-2006
  • Reported Cases of HIV & AIDS, and AIDS Related Deaths, 1995-2006

CHARTS

• Map of Finland
• Population by Age Group, 2005 (%)
• Leading Causes of Death, 2005 (%)

FINLAND HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
  • Health Expenditure at Current Prices, 1985-2004 (million euros)
  • Health Expenditure by Category, 1998-2004 (million euros)
  • Outpatient Expenditure by Category, 1994-2000 (million euros)
• HOSPITAL SERVICES
  • Hospitals by Type, 1998
  • Hospital Beds, 1993-2003
• Hospital Activity
  • Inpatient Activity Summary, 1990-2004
  • Average Length of Stay by Healthcare Provision, 2003 (days)
  • Average Length of Stay by Hospital Type, 1992-2001
  • Average Length of Stay by Speciality, 1995-2003
  • Inpatient Primary Healthcare Patient Numbers, 1997-2003
  • Inpatient Primary Healthcare Patient Days by Significant Disease Groups, 1997-2003
  • Inpatient Specialised Healthcare Patient Numbers, 1997-2003
  • Inpatient Specialised Healthcare Patient Days, 1997-2003
  • Average Length of Stay in Specialised Healthcare by Disease Classification, 1997-2003 (Days)
• Hospital Procedures
  • Patient Numbers for Common Operations and Procedures, 1997-2003
  • Care Days for Operations and Procedures, 1997-2003
  • Average Length of Stay for Common Operations and Procedures, 1997-2003 (days)
• AMBULATORY CARE
  • Outpatient Visits to Health Centres by Type of Activity, 1998-2003
  • Outpatient Visits to Specialist Outpatient Centres by Specialty, 1999-2003
  • Dental Visits, 1997-2003
• MEDICAL PERSONNEL
  • Healthcare Professionals of Working Age, 2002-2003
  • Healthcare Professionals of Working Age, 1995-2003
  • Physicians of Working Age by specialty, 2004

CHARTS

• Health Expenditure by Category, 2004 (%)
• Health Expenditure, 1985-2004
• Total Admissions and ALOS, 1990-2004

FINLAND ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
  • European Union Regulatory Reforms
  • Centralised Procedure
  • The EMEA
  • Mutual Recognition Procedure
• Pharmaceutical Registration
• Advertising
• Patent Protection & Intellectual Property Rights
  • Supplementary Protection Certificates
• Pricing and Reimbursement
  • Reimbursement
  • Drug Price Structure
• DISTRIBUTION CHANNELS
  • Pharmacies, 1980-2005
• Distributors
• DOMESTIC PRODUCTION
  • Summary of Domestic Production, 2000-2005 (euro thousands)
  • Summary of Manufacturing Facilities and Employees, 2000-2005
• Trade Associations
  • PIF member companies, 2006
• Domestic Producers
• Research & Development
• DIRECTORY

CHARTS

• Average Drug Price Structure, 2004

LATVIA BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
• POPULATION
  • Population, 1994-2006
  • Population by Area, 1994-2006
  • Population of Major Cities, 2001-2006
  • Population by Age Group, 2000-2006
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 1997-2005
• MORTALITY
  • Leading Causes of Death, 2005
  • Leading Causes of Death, 2000-2004
    • Infant Mortality
  • Leading Causes of Infant Death, 2002-2005
• MORBIDITY
  • Communicable/infectious diseases
  • Reported Infectious Diseases, 2000-2005
    • Cancer
  • Cancer Incidence, 1998-2005
    • Tuberculosis
  • TB Cases, 1998-2005
    • HIV/AIDS
  • Cumulative Reported Cases of HIV and AIDS, 1999-2005

CHARTS

• Map of Latvia
• Population by Age, 2006 (%)
• Causes of Death, 2005 (%)

LATVIA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• Public sector
• Private sector
• HEALTH EXPENDITURE
• HOSPITAL SERVICES
  • Hospitals and Beds, 2000-2005
  • Hospital Beds by Regional Sickness Fund, 2000-2001
  • Beds by Specialty and Operator, 2002
  • Hospital Beds by Specialty, 1999-2005
• Hospital Activity
  • Hospital Activity, 1998-2005
    • Surgical procedures
  • Surgical Operations Performed, 1999-2004
• AMBULATORY CARE
  • Outpatient Facilities, 2000-2005
  • Outpatient Visits, 1998-2005
• MEDICAL PERSONNEL
  • Physicians by Specialty, 2001-2005
  • Personnel by Employer and Region, 2001
  • Other Medical Staff, 2000-2005

LATVIA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• Pharmaceutical Registration
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing and Reimbursement
• DISTRIBUTION CHANNELS
  • Hospital purchasing
• Distributors
  • Farmserviss
  • Magnum Medical
  • Mepha Latvia
  • Recipe Plus
  • Tamro SIA
• DOMESTIC PRODUCTION
• Trade Associations
  • Latvian Chamber of Commerce & Industry
• Domestic Producers
  • Kalceks
  • Grindex
  • Olainfarm
• DIRECTORY
• Healthcare Organisations
• Trade Associations

LITHUANIA BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • Economic Indicators, 2004-2011
• POPULATION
  • Population, 1990-2006 (000s)
  • Population by Area, 1990-2006 (000s)
• DEMOGRAPHIC INDICATORS
  • Principal Demographic Indicators, 1998-2005
• MORTALITY
  • Causes of Death, 1995-2004
    • Infant mortality
  • Infant Deaths by Cause, 2004
• MORBIDITY
  • Infectious diseases
  • Selected Notifiable Diseases, 1999-2004
    • HIV & AIDS
  • Reported Incidence of and Deaths from HIV & AIDS, 1995-2004
    • Cancer
  • Incidence and Prevalence of Malignant Neoplasms, 1997-2004
  • New Cancer Cases by Leading Site, 2001

CHARTS

• Map of Lithuania
• Population by Age Group, 2006 (%)
• Birth & Death Rates, 1995-2005
• Causes of Death, 2004 (%)

LITHUANIA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
  • Health Expenditure, 1999-2004 (LTL millions)
  • CHIF Expenditure by Type, 2003
• HOSPITAL SERVICES
• Hospital Resources
  • Hospitals & Beds, 1996-2004
  • Hospitals by Specialty, 2003-2004
  • Hospital Beds by Specialty, 1996-2001
• Hospital Activity
  • Hospital Activity, 1996-2004
  • Discharges of Adults by Diagnosis, 1995-2004 (Per 1,000 Population)
  • Discharges of Children by Diagnosis, 1995-2004 (Per 000 Population)
    • Surgical Procedures
  • Surgical Procedures in Hospitals, 1997-2004
• AMBULATORY CARE
  • Outpatient Facilities, 2003-2004
  • First Aid Services, 1995-2001
  • Doctor and Dentist Visits, 1996-2004
• MEDICAL PERSONNEL
  • Medical Personnel, 1995-2004
  • Doctors by Specialty, 2000-2003

CHARTS

• Health Expenditure by Source, 2004 (%)

LITHUANIA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• Pharmaceutical Registration
  • Marketing Authorisation
  • Marketing Authorisation Applications & Renewals, 2004-2005
  • Evaluated Marketing Authorisation Applications & Renewals, 2004-2005
    • Post-market Surveillance
    • Quality Control
    • Clinical Trials
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing & Reimbursement
• DISTRIBUTION CHANNELS
• Distributors
  • Asotra
  • Armedika
  • Armila
  • Entafarma
  • Tamro
  • K. Backevicius Personal Enterpise (Korys)
• TRADE FAIRS
• DOMESTIC PRODUCTION
• Domestic Producers
  • Sanitas
  • Sanitas' Sales, 1998-2005 (LTL millions)
• DIRECTORY
• Government Organisations
• Trade Associations

NORWAY BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
• POPULATION
  • Population, 1994-2006
  • Population by County, 2004-2006
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 1999-2005
• MORTALITY
  • Causes of Death, 2001-2003
  • Causes of Death 2004
• MORBIDITY
  • Individually Notified Cases of Infectious Diseases, 2000-2005
    • Tuberculosis
  • Notified Cases of Tuberculosis, 1995-2004
    • Cancer
  • New Cases of Cancer by Primary Site and Sex, 2005
    • HIV/AIDS
  • HIV /AIDS cases, 1984-2005

CHARTS

• Map of Norway
• Population by Age Group, 2006 (%)

NORWAY HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
  • Health Expenditure by Function of Care, 2001-2006 (NOK millions)
  • Health Expenditure by function and Source of Funding, 2004 (%)
• HOSPITAL SERVICES
  • Number of Health Institutions, 1998
  • Number of Beds by Type of Institution, 2000-2004
  • Beds in Somatic Hospitals by Specialty, 1995-2000
    • Elderly Care Beds
  • Beds in Institutions for the Aged, 1999-2004
• Hospital Activity
  • Patient Activity in Healthcare Institutions, 1999-2004
  • Discharges from Somatic Hospitals by Diagnosis, 2005
  • Discharges from General Hospitals by Diagnosis, 2002-2005
    • Day Cases
  • General Hospital Day Cases, 2006
  • General Hospital Day Cases, 2002-2006
• AMBULATORY CARE
  • Hospital Outpatient Care
  • Outpatient Consultations, 2004-2006
• MEDICAL PERSONNEL
  • Physicians by Specialty, June 2005
  • Dentists & Other Dentistry Staff, 2003-2004

NORWAY ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• Pharmaceutical Registration
  • Centralised Procedure
  • The EMEA
  • Mutual Recognition Procedure
• Patent Protection & Intellectual Property Rights
• Pricing and Reimbursement
  • Pharmacoeconomic Analyses
• DISTRIBUTION CHANNELS
• Distributors
  • Holtung AS
  • Norsk Medisinaldepot AS
  • Tamro Distribution AS
• Parallel Imports
  • Parallel Imported Drug Sales, 1995-2004
• DOMESTIC PRODUCTION
• Trade Associations
• Domestic Producers
• Research & Development
  • R&D Expenditure, 1995-2005
• DIRECTORY

SWEDEN BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • Gross Domestic Product, 2007-2012
• POPULATION
  • Population by County, 2005-2006
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 1998-2006
• MORTALITY
  • Registered Causes of Death, 2000-2003
• MORBIDITY
  • Leading Notifiable Infectious Diseases, 1998-2004
    • Cancer
  • Cancer, Reported Cases by Site, 2002-2004
    • HIV/AIDS
  • HIV/AIDS Cases, 1990-2005

CHARTS

• Map of Sweden
• Population by Age Group, 2005 (%)
• Leading Causes of Death, 2003 (%)

SWEDEN HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
  • Health Expenditure by Sector, 2000-2005 (SEK million)
• County Council Financing
• Patient Fees
• HOSPITAL SERVICES
• Hospital Resources
  • Public Hospital Trends, 1997-2005
  • Public Hospitals by Type, 1999
  • Public Hospital Beds by Type, 1995-2003
  • Public Hospital Beds by Specialty, 2002 & 2003
  • Public Hospital Beds by Region & Type, 2003
• Hospital Activity
  • Admissions
  • Inpatient Admissions by Disease, 2001-2005
  • Inpatient Admissions by Sex and Disease, 2005
    • Average Length of Stay (ALOS)
  • ALOS by Hospital Type, 1994-1999 (Days)
    • Hospital Discharges
  • Discharges by Hospital Type, 1994-1999 (000s)
  • Bed Days by Hospital Type, 1996-1999 (000s)
• AMBULATORY CARE
  • Outpatient Visits to Doctors by Sector & County, 1999 (000s)
    • Dental Care
  • Public Sector Dental Care, 1990-1998
• MEDICAL PERSONNEL
  • Doctors, 1990-2020
  • Public Sector Medical Personnel 1999-2003
  • Doctors by County, 2005
  • Doctors by Specialty, 2005
  • Other Medical Personnel, 1997-2000

SWEDEN ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• National Procedure
• European Union Regulatory Reforms
• Marketing Authorisations
• Registration Fees
  • Market Authorisation Fees
  • Marketing Authorisation Fees (SEK)
    • Annual Registration Fees
  • Annual Registration Fees (SEK)
    • Labelling & Packaging
    • Post-Marketing Surveillance
    • Clinical Trials
• Pharmaceutical Product Approvals
  • Approved Pharmaceutical Products, 1985-2005
  • Approved New Chemical Entities and Average Processing Period, 1985-2005
• Patent Protection & Intellectual Property Rights
• Pricing and Reimbursement
  • Criteria for reimbursement
  • Cost effectiveness
  • Appealing Decisions
• Generic Substitution
  • Price decline for off-patent drugs
• DISTRIBUTION CHANNELS
  • VAT and Import Duty
  • Pharmacies
  • Pharmacies, 1980-2005
• Distributors
  • Kronans Droghandel AB (KD AB)
  • Tamro Sweden
• Wholesale Distribution Authorisation
• Parallel Imports
  • Parallel Imported Pharmaceutical Market, 1997-2005
• DOMESTIC PRODUCTION
  • Domestic Production, 2001-2004 (SEK 000s)
  • Leading Pharmaceutical Manufacturers by Sales, 2005
• Trade Associations
• Domestic Producers
• Multinationals
• Research & Development
• DIRECTORY
• Government Organisations
• Trade Associations

CHARTS

• R&D Clinical Costs, 1999-2005 (SEK billions)